fda semaglutide shortage resolved 2025 announcement Federal judge upholds FDA's removal of Ozempic, Wegovy from drug list FDA Declares Wegovy and Ozempic

A small ziplock bag for organizing supplies and keeping them dry

Older adults with type 2 diabetes are less likely to have a cardiovascular event if they are initially prescribed an SGLT2 inhibitor or GLP-1 receptor agonist instead of a DPP-IV inhibitor, according to findings published in Diabetes Care

Direct effects on the sinoatrial node or cardiac tissue may also play a role, as GLP-1 receptors have been identified in cardiac tissue

Tirzepatide and GLP-3R were more effective than Liraglutide in reducing uric acid, urine volume, creatinine, urinary albumin excretion rate, and urinary albumin-to-creatinine ratio, with GLP-3R showing the most pronounced improvements in creatinine levels, urinary albumin-to-creatinine ratio, and urinary albumin excretion rate

J., Behrends, T., Eckstein, A